# Iovance Biotherapeutics, Inc. (IOVA): Dividend & Fundamentals

> Markdown mirror of https://www.dividenddata.com/stocks/iova for AI agents. Same live data as the HTML page, regenerated on the same refresh cycle. Not investment advice.

- Sector: Healthcare · Industry: Biotechnology
- Exchange: NASDAQ · Trading currency: USD

Iovance Biotherapeutics, Inc., a biotechnology firm currently in the clinical development stage, is committed to discovering and bringing to market cancer immunotherapy solutions. Its core mission involves leveraging the patient's own immune system to effectively combat and eradicate cancerous cells. The company is presently conducting six Phase 2 clinical trials. These include study C-144-01, evaluating its primary experimental compound, lifileucel, for individuals with advanced melanoma. Another trial, C-145-04, is assessing lifileucel's potential for treating cervical cancer that is recu...

## Quote & Key Metrics

As of 2026-10-23:

| Metric | Value |
|---|---|
| Price | $14.09 USD |
| Market Cap | $6.38B |
| P/E (TTM) | — |
| EPS (TTM) | −$0.73 |
| 52-Week Range | $1.76 – $15.37 |
| Dividend Yield (TTM) | — |

## Dividend

IOVA has no dividend payment history in our records.

## Frequently Asked Questions

### What does Iovance Biotherapeutics, Inc. do?

Iovance Biotherapeutics, Inc. (IOVA) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

### What is IOVA's market cap?

Iovance Biotherapeutics, Inc. (IOVA) has a market capitalization of approximately $6.38 billion, as of October 23, 2026, based on the most recent share price and shares outstanding.

### Does IOVA pay a dividend?

No, Iovance Biotherapeutics, Inc. (IOVA) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

### Is IOVA profitable?

Iovance Biotherapeutics, Inc. (IOVA) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

### Has IOVA ever paid a dividend?

No. Dividend Data's records show no dividend payments from Iovance Biotherapeutics, Inc. (IOVA). A first dividend would appear on the Dividend tab once it is declared.

## More on Dividend Data

- Overview (HTML): https://www.dividenddata.com/stocks/iova
- Dividend history & safety: https://www.dividenddata.com/stocks/iova/dividend
- Earnings & EPS: https://www.dividenddata.com/stocks/iova/earnings
- Financial statements: https://www.dividenddata.com/stocks/iova/financials/income
- Valuation multiples: https://www.dividenddata.com/stocks/iova/valuation
- Peer comparison: https://www.dividenddata.com/stocks/iova/peers

Data sourced from primary filings and market data providers; see https://www.dividenddata.com/methodology.